000 | 01203 a2200337 4500 | ||
---|---|---|---|
005 | 20250514214939.0 | ||
264 | 0 | _c20050318 | |
008 | 200503s 0 0 eng d | ||
022 | _a0885-0615 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMaloney, Dennis M | |
245 | 0 | 0 |
_aInstitutional review boards (IRBs) and risk considerations for children. _h[electronic resource] |
260 |
_bHuman research report _cSep 2004 |
||
300 |
_a1-3 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 |
_aAttention Deficit Disorder with Hyperactivity _xdrug therapy |
650 | 0 | 4 | _aChild |
650 | 0 | 4 |
_aDextroamphetamine _xadverse effects |
650 | 0 | 4 | _aEthical Review |
650 | 0 | 4 | _aEthics Committees, Research |
650 | 0 | 4 | _aGovernment Regulation |
650 | 0 | 4 |
_aHuman Experimentation _xlegislation & jurisprudence |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aNational Institute of Mental Health (U.S.) |
650 | 0 | 4 |
_aNontherapeutic Human Experimentation _xlegislation & jurisprudence |
650 | 0 | 4 | _aRisk Assessment |
650 | 0 | 4 | _aUnited States |
650 | 0 | 4 | _aUnited States Food and Drug Administration |
773 | 0 |
_tHuman research report _gvol. 19 _gno. 9 _gp. 1-3 |
|
999 |
_c15352983 _d15352983 |